Effects of S-1 and Capecitabine on Coronary Artery Blood Flow

NCT02216149 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Esophagus Cancer
Stomach Cancer
Small Bowel Cancer
Colon Cancer
Rectum Cancer

Interventions

DRUG: S-1
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Heikki Joensuu